Results demonstrate a significant survival benefit in the cTMB-H / HRP subset: median OS of almost 6 years (68 months) with Vigil vs. less than 2 years (19 months) for placebo (HR=0.23; p=0.008)7-year ...
7h
Accessibility lawsuits rose by 37% in 2025: Why small businesses can no longer ignore their websites
Clym reports a 37% rise in ADA website accessibility lawsuits in 2025, impacting small e-commerce businesses significantly.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback